Asthma is the most prevalent chronic respiratory disease worldwide and despite advances in our understanding of asthma and its treatment, it continues to be associated with significant, and largely preventable, morbidity and mortality [1, 2]. In this issue of ERJOR, Noorduyn et al. add data to the growing literature showing that SABA overuse in asthma is both common and associated with severe exacerbations. It is time to take note and act to tackle this global issue. https://bit.ly/3BfwhfS
No takes yet. Share an insight, caveat, or question.
Crooks et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: